BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37685323)

  • 1. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses.
    Pelayo M; Pelayo-Delgado I; Sancho-Sauco J; Sanchez-Zurdo J; Abarca-Martinez L; Corraliza-Galán V; Martin-Gromaz C; Pablos-Antona MJ; Zurita-Calvo J; Alcázar JL
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions.
    Czekierdowski A; Stachowicz N; Smolen A; Łoziński T; Guzik P; Kluz T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
    Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic Assessment of Complex Ultrasound Morphology Adnexal Tumors in Pregnant Women with the Use of IOTA Simple Rules Risk and ADNEX Scoring Systems.
    Czekierdowski A; Stachowicz N; Smoleń A; Kluz T; Łoziński T; Miturski A; Kraczkowski J
    Diagnostics (Basel); 2021 Feb; 11(3):. PubMed ID: 33671023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating use of IOTA two-step strategy to classify adnexal masses identified in pregnancy: pilot study.
    Barcroft J; Pandrich M; Del Forno S; Cooper N; Linton-Reid K; Landolfo C; Timmerman D; Saso S; Bourne T
    Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38787921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
    Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
    Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
    Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
    Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of performance between O-RADS, IOTA simple rules risk assessment and ADNEX model in the discrimination of ovarian Brenner tumors.
    Shang J; Lei T; Wu L; Lin M; Xie H
    Arch Gynecol Obstet; 2023 Sep; 308(3):961-970. PubMed ID: 37186266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of O-RADS, GI-RADS, and ADNEX for Diagnosis of Adnexal Masses: An External Validation Study Conducted by Junior Sonologists.
    Lai HW; Lyu GR; Kang Z; Li LY; Zhang Y; Huang YJ
    J Ultrasound Med; 2022 Jun; 41(6):1497-1507. PubMed ID: 34549454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
    Poonyakanok V; Tanmahasamut P; Jaishuen A
    J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.